UdayanGuhaMDPhD

Oncology • New York, NY

Hematologic Oncology

Director, Early Clinical Development, Bristol Myers Squibb and Special Volunteer, Thoracic and GI Malignancies Branch, NCI, NIH

Join to view full profile

Dr. Guha is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Guha's full profile

Already have an account?

Office
1275 York Ave
Department of Medicine Box 8
New York, NY 10065
Phone+1 212-639-2282

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2003 - 2006
All India Institute of Medical SciencesClass of 1995

Certifications & Licensure

NY State Medical License 2008 - 2025
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Phase I Study of MGAH22 in Patients With Refractory HER2 Positive Cancers Start of enrollment: 2010 Aug 01
Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies Start of enrollment: 2011 Feb 08
Active, not recruiting
Phase 2
Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib Start of enrollment: 2016 Apr 13
Completed
Phase 2

Publications & Presentations

PubMed

135 citations
Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins
Marianne S. Poruchynsky, Edina Komlodi-Pasztor, Shana Y. Trostel, Julia Wilkerson, Marie Regairaz
Proceedings of the National Academy of Sciences of the United States of America. 2015-02-03
106 citations
Keratinocyte expression of calcitonin gene-related peptide β: implications for neuropathic and inflammatory pain mechanisms.
Quanzhi Hou, Travis P. Barr, Lucy Gee, Jeff Vickers, James Wymer
Pain. 2011-09-01
2 citations
Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics.
Catherine M Ade, Matthew J Sporn, Sudipto Das, Zhiya Yu, Ken-Ichi Hanada
Journal for Immunotherapy of Cancer. 2023-09-01

Press Mentions

NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024September 16th, 2024